Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Tekmira’s Ebola Drug Gets Regulatory Framework

September 22, 2014 2:56 pm | News | Comments

Tekmira Pharmaceuticals Corp. announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access protocols to subjects with confirmed or suspected Ebola virus infections. Read more...          

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Pterostilbene Prevents Skin Damage from UV Exposure in Mouse Study

September 22, 2014 4:04 pm | News | Comments

ChromaDex Corp. announced the completion of an animal skincare study of pterostilbene by researchers at The University of California Irvine (UCI). Read more...                          

TOPICS:

Metformin Linked to Risk of Low Levels of Thyroid Hormone

September 22, 2014 4:03 pm | News | Comments

Metformin, a commonly used drug for treating type 2 diabetes, is linked to an increased risk of low thyroid-stimulating hormone (TSH) levels in patients with underactive thyroids (hypothyroidism), according to a new study. Read more...      

TOPICS:

New Chip Promising for Tumor-Targeting Research

September 22, 2014 3:59 pm | News | Comments

Researchers have developed a chip capable of simulating a tumor's "microenvironment" and plan to use the new system to test the effectiveness of nanoparticles and drugs that target cancer. Read more...              

TOPICS:
Advertisement

Amgen Submits BLA for Investigational Cancer Immunotherapy

September 22, 2014 3:54 pm | News | Comments

Amgen announced submission of a Biologics License Application (BLA) to the FDA seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab. Read more...                

TOPICS:

Researchers Describe New Cancer Drug Target Involving Lipid Chemical Messengers

September 22, 2014 10:11 am | News | Comments

More than half of human cancers have abnormally upregulated chemical signals related to lipid metabolism, yet how these signals are controlled during tumor formation is not fully understood. Researchers are reporting that TIPE3, a newly described oncogenic protein, promotes cancer by targeting these pathways. Read more...

TOPICS:

Japan Approves Bayer's Eylea for Myopic Choroidal Neovascularization

September 22, 2014 9:58 am | News | Comments

Bayer HealthCare has received approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Eylea (aflibercept solution for injection) for the treatment of myopic choroidal neovascularization (myopic CNV). Read more...     

TOPICS:

Spain: Ebola Test Drug Out of Supply Worldwide

September 22, 2014 9:19 am | News | Comments

Doctors treating a Spanish priest who was repatriated from West Africa on Monday after being diagnosed with the Ebola virus said there were no samples of experimental drug ZMapp available in the world right now. Read more...        

TOPICS:

Germany's Merck to Buy Sigma Aldrich for $17B

September 22, 2014 7:40 am | by David McHugh, AP Business Writer | News | Comments

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion. Darmstadt-based Merck KGaA said Monday it is paying $140 per share in cash for all of Sigma-Aldrich's share. Read more...

TOPICS:
Advertisement

Soligenix Gets $24.7M for Development of Heat-Stable RiVax Vaccine

September 19, 2014 10:28 am | News | Comments

Soligenix Inc. announced that it has been awarded a contract valued at up to $24.7 million to advance the development of Soligenix’s thermostabilization technology, ThermoVax, combined with the company’s ricin toxin vaccine, RiVax. Read more...  

TOPICS:

Modified Antibiotic Can Vanquish Resistant Bacteria

September 19, 2014 10:23 am | News | Comments

Scientists have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria. Read more...                   

TOPICS:

A New Way to Prevent the Spread of Devastating Diseases

September 19, 2014 10:18 am | News | Comments

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, there are still no licensed vaccinations available that can protect against these diseases. Now, researchers are approaching the problem in a different way. Read more...

TOPICS:

Pfizer Provides $2M to Support ‘Last-Mile’ Vaccine Coverage

September 19, 2014 10:04 am | News | Comments

The Pfizer Foundation announced $2 million in grant funding for pilot programs to improve immunization coverage in Africa. Grant recipients include UNICEF, Save the Children and International Rescue Committee. Read more...      

TOPICS:

New Approach to Arthritis Drug Delivery Could Help Avoid Side Effects

September 19, 2014 9:54 am | News | Comments

A new approach to arthritis treatment, which avoids unforeseen side effects by delivering drugs exclusively to affected inflamed joints, has been developed by researchers in London. Read more...                

TOPICS:

Gilead Cancer Drug Approved in Europe

September 19, 2014 9:22 am | News | Comments

Gilead Sciences Inc. announced that the European Commission has granted marketing authorization for Zydelig (idelalisib), a first-in-class oral treatment for chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). Read more...     

TOPICS:

China Fines GSK $492M for Bribery

September 19, 2014 9:13 am | by Joe McDonald, AP Business Writer | News | Comments

Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China in the biggest such penalty ever imposed by a Chinese court. Read more...                         

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading